Bob Wu
Director/Board Member bei NOVABAY PHARMACEUTICALS
Vermögen: 180 $ am 31.03.2024
Profil
Mi Jia Wu is currently a Non-Independent Director at NovaBay Pharmaceuticals, Inc., a Managing Director at China Kington Asset Management Co. Ltd., and the Owner of Striker Pharma (Singapore) Pte Ltd.
Previously, Wu held positions as a Director at UBS AG (Hong Kong Branch), a Non-Executive Director at Shanghai Pioneer Holding Ltd., and a Managing Director at China Kington Investment Co. Ltd.
and Shanghai Ceton Investment Management Co. Ltd.
Wu also worked as a Vice President at BNP Paribas SA (Hong Kong Branch) and an Assistant Vice President at ABN Amro Bank (China) Co. Ltd.
Wu holds an MBA from Cheung Kong Graduate School of Business and Manchester Business School, and an undergraduate degree from Guangdong University of Foreign Studies.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.03.2024 | 1 716 ( 0,01% ) | 180 $ | 31.03.2024 |
Aktive Positionen von Bob Wu
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVABAY PHARMACEUTICALS | Director/Board Member | 26.01.2016 |
Striker Pharma (Singapore) Pte Ltd.
 Striker Pharma (Singapore) Pte Ltd. Financial ConglomeratesFinance Striker Pharma (Singapore) Pte Ltd. distributes pharmaceutical products. The company is headquartered in Singapore. | Corporate Officer/Principal | - |
China Kington Asset Management Co. Ltd.
 China Kington Asset Management Co. Ltd. Investment ManagersFinance China Kington Asset Management Co. Ltd. engages in providing asset management services. Its businesses encompass fund establishment and management, accepting trust of investment funds from domestic and international investors and organizations, to be used either as direct investment or securities investment, including Pre-IPO, IPO and APO. The company is headquartered in Shanghai, China. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Bob Wu
| Unternehmen | Position | Ende |
|---|---|---|
| SHANGHAI PIONEER HOLDING LTD | Director/Board Member | 31.12.2021 |
UBS AG (Hong Kong Branch)
 UBS AG (Hong Kong Branch) Investment Banks/BrokersFinance Part of UBS Group AG, UBS AG (Hong Kong Branch) is a Chinese company that provides investment banking securities dealing services. The private company is based in Hong Kong, Hong Kong. | Director/Board Member | 01.08.2007 |
BNP Paribas SA (Hong Kong Branch)
 BNP Paribas SA (Hong Kong Branch) Major BanksFinance Part of BNP Paribas SA, BNP Paribas SA (Hong Kong Branch) is a banking and financing company based in Hong Kong, Hong Kong. The Chinese company provides banking, financing, and advisory services to local and overseas corporations, financial institutions, and institutional investors. The private company was founded in 1862. Pak Hon Leung has been the CEO of the company since 2019. | Corporate Officer/Principal | 01.12.2006 |
| ABN Amro Bank (China) Co. Ltd. | Corporate Officer/Principal | 01.06.2005 |
| Shanghai Ceton Investment Management Co. Ltd. | Corporate Officer/Principal | - |
Ausbildung von Bob Wu
| Cheung Kong Graduate School of Business | Masters Business Admin |
| Guangdong University of Foreign Studies | Undergraduate Degree |
| Manchester Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVABAY PHARMACEUTICALS | Health Technology |
| SHANGHAI PIONEER HOLDING LTD | Distribution Services |
| Private Unternehmen | 7 |
|---|---|
Striker Pharma (Singapore) Pte Ltd.
Striker Pharma (Singapore) Pte Ltd. Financial ConglomeratesFinance Striker Pharma (Singapore) Pte Ltd. distributes pharmaceutical products. The company is headquartered in Singapore. | Finance |
BNP Paribas SA (Hong Kong Branch)
BNP Paribas SA (Hong Kong Branch) Major BanksFinance Part of BNP Paribas SA, BNP Paribas SA (Hong Kong Branch) is a banking and financing company based in Hong Kong, Hong Kong. The Chinese company provides banking, financing, and advisory services to local and overseas corporations, financial institutions, and institutional investors. The private company was founded in 1862. Pak Hon Leung has been the CEO of the company since 2019. | Finance |
UBS AG (Hong Kong Branch)
UBS AG (Hong Kong Branch) Investment Banks/BrokersFinance Part of UBS Group AG, UBS AG (Hong Kong Branch) is a Chinese company that provides investment banking securities dealing services. The private company is based in Hong Kong, Hong Kong. | Finance |
China Kington Investment Co. Ltd.
 China Kington Investment Co. Ltd. Investment ManagersFinance China Kington Investment Co. Ltd. provides investment advice. The private company is based in Hong Kong, Hong Kong. | Finance |
China Kington Asset Management Co. Ltd.
China Kington Asset Management Co. Ltd. Investment ManagersFinance China Kington Asset Management Co. Ltd. engages in providing asset management services. Its businesses encompass fund establishment and management, accepting trust of investment funds from domestic and international investors and organizations, to be used either as direct investment or securities investment, including Pre-IPO, IPO and APO. The company is headquartered in Shanghai, China. | Finance |
| ABN Amro Bank (China) Co. Ltd. | |
| Shanghai Ceton Investment Management Co. Ltd. |
